Imaging Endpoints (IE) announced that Dr. Antonio Fojo was chosen to join their Scientific Advisory Board, a global group of leading medical professionals appointed to provide strategic insight and imaging-related expertise for optimizing the opportunity to demonstrate efficacy in clinical trials.
Dr. Fojo is currently a professor of medicine at Columbia University Irving Medical Center and the co-director of the Carling Adrenal Surgery Center, the world's largest endocrine surgery center. Known for his research toward reversing cancer chemotherapy resistance, Dr. Fojo's work in tumor growth kinetics (TGK) has been instrumental in advancing the field. His work has shown how a drug's anticancer properties are better demonstrated by tumor growth rate and fraction of tumor killed (as compared to indirect measures such as response rate or progression-free survival).
Dr. Fojo's expertise in adrenocortical cancer, thyroid cancer, and neuroendocrine malignancies — coupled with his involvement in the design, management, and interpretation of clinical trials — makes him particularly passionate about developing additional therapies and expanding treatment options for patients with these cancers.
Dr. Fojo is also particularly interested in the molecular basis of drug resistance and has been integral to several important discoveries in the matter, including the identification of molecular events shown to be influential in the treatment of ovarian cancer. Additionally, as a Principal Investigator for the Medicine Branch of the National Cancer Institute, he established a successful translational clinical program to develop therapeutic treatments for endocrine and neuroendocrine cancers.
Dr. Fojo's new board colleagues are an acclaimed group of clinical experts, including Daniel Von Hoff, M.D., F.A.C.P.; David Sidransky, M.D.; Elliot Fishman, M.D.; Bruce Cheson, M.D., F.A.C.P., F.A.A.S.; Manuel Hidalgo, M.D., PhD.; and Axel Hanauske, M.D., Ph.D., MBA. The Scientific Advisory Board leverages their expertise to advise Imaging Endpoints on the imaging design for global clinical trials wherein IE is providing its Imaging CRO services.
Source: Imaging Endpoints
